Advertisement

Topics

Homology Medicines to Present at Bank of America Merrill Lynch Health Care Conference

20:00 EDT 8 May 2019 | Globe Newswire

BEDFORD, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today that Company management will participate during a fireside chat at the 2019 Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, at 4:20 p.m. PT at the Encore Hotel in Las Vegas.

In addition, Arthur Tzianabos, Ph.D., President and Chief Executive Officer of Homology Medicines, will participate in the Gene Therapy Panel being held at the conference on Wednesday, May 15, at 4:20 p.m. PT (not webcast). 

The live webcast of the fireside chat will be accessible on Homology’s website in the Investors section, and the webcast replay will be available on the website for 90 days following the presentation.

About Homology Medicines, Inc.
Homology Medicines, Inc. is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Homology’s proprietary platform is designed to utilize its human hematopoietic stem cell-derived adeno-associated virus vectors (AAVHSCs) to precisely and efficiently deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a broad range of genetic disorders. Homology has a management team with a successful track record of discovering, developing and commercializing therapeutics with a particular focus on rare diseases, and intellectual property covering its suite of 15 AAVHSCs. Homology believes that its compelling preclinical data, scientific expertise, product development strategy, manufacturing capabilities and intellectual property position it as a leader in the development of genetic medicines. For more information, please visit www.homologymedicines.com.

Investor & Media Contact:
Theresa McNeely
SVP, Corporate Communications
& Patient Advocacy
tmcneely@homologymedicines.com
781-691-3751

HMI Logo_020216.jpg

NEXT ARTICLE

More From BioPortfolio on "Homology Medicines to Present at Bank of America Merrill Lynch Health Care Conference"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...